Interstitial lung disease in newborns

Deutsch, 2007, Diffuse lung disease in young children: application of a novel classification scheme, Am J Respir Crit Care Med, 176, 1120, 10.1164/rccm.200703-393OC Griese, 2015, Categorizing diffuse parenchymal lung disease in children, Orphanet J Rare Dis, 10, 122, 10.1186/s13023-015-0339-1 Langston, 2009, Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies, Pediatr Dev Pathol, 12, 421, 10.2350/08-11-0559.1 O'Reilly, 2015, Diffuse lung disease in infants less than 1 year of age: histopathological diagnoses and clinical outcome, Pediatr Pulmonol, 50, 1000, 10.1002/ppul.23124 Rice, 2013, Diffuse lung disease in infancy and childhood: expanding the chILD classification, Histopathology, 63, 743, 10.1111/his.12185 Hime, 2015, Childhood interstitial lung disease: a systematic review, Pediatr Pulmonol, 50, 1383, 10.1002/ppul.23183 Cassidy, 2002, The incidence and characteristics of neonatal irreversible lung dysplasia, J Pediatr, 141, 426, 10.1067/mpd.2002.126602 Barnett, 2016, Ectrodactyly and lethal pulmonary acinar dysplasia associated with homozygous FGFR2 mutations identified by exome sequencing, Hum Mutat, 37, 955, 10.1002/humu.23032 Szafranski, 2016, Phenotypic expansion of TBX4 mutations to include acinar dysplasia of the lungs, Am J Med Genet A, 170, 2440, 10.1002/ajmg.a.37822 Edwards, 2005, Ultrastructure of lamellar bodies in congenital surfactant deficiency, Ultrastruct Pathol, 29, 503, 10.1080/01913120500323480 Hugosson, 2005, Primary alveolar capillary dysplasia (acinar dysplasia) and surfactant protein B deficiency: a clinical, radiological and pathological study, Pediatr Radiol, 35, 311, 10.1007/s00247-004-1349-7 Stankiewicz, 2009, Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations, Am J Hum Genet, 84, 780, 10.1016/j.ajhg.2009.05.005 Sen, 2013, Novel FOXF1 mutations in sporadic and familial cases of alveolar capillary dysplasia with misaligned pulmonary veins imply a role for its DNA binding domain, Hum Mutat, 34, 801, 10.1002/humu.22313 Szafranski, 2014, Two deletions overlapping a distant FOXF1 enhancer unravel the role of lncRNA LINC01081 in etiology of alveolar capillary dysplasia with misalignment of pulmonary veins, Am J Med Genet A, 164A, 2013, 10.1002/ajmg.a.36606 Szafranski, 2016, Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins, Hum Genet, 135, 569, 10.1007/s00439-016-1655-9 Sen, 2013, A familial case of alveolar capillary dysplasia with misalignment of pulmonary veins supports paternal imprinting of FOXF1 in human, Eur J Hum Genet, 21, 474, 10.1038/ejhg.2012.171 Luk, 2016, Maternal somatic mosaicism of FOXF1 mutation causes recurrent alveolar capillary dysplasia with misalignment of pulmonary veins in siblings, Am J Med Genet A, 170, 1942, 10.1002/ajmg.a.37660 Guillerman, 2011, Contemporary perspectives on pediatric diffuse lung disease, Radiol Clin North Am, 49, 847, 10.1016/j.rcl.2011.06.004 Langston, 2006, A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the chILD pathology co-operative group, Pediatr Dev Pathol, 9, 173, 10.2350/06-03-0065.1 Hintz, 1999, Alveolar capillary dysplasia: diagnostic potential for cardiac catheterization, J Perinatol, 19, 441, 10.1038/sj.jp.7200243 Lord, 2014, Filamin A mutation may be associated with diffuse lung disease mimicking bronchopulmonary dysplasia in premature newborns, Respir Care, 59, e171, 10.4187/respcare.02847 Hamvas, 2013, Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1, Chest, 144, 794, 10.1378/chest.12-2502 Nogee, 1994, A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds, J Clin Invest, 93, 1860, 10.1172/JCI117173 Shulenin, 2004, ABCA3 gene mutations in newborns with fatal surfactant deficiency, N Engl J Med, 350, 1296, 10.1056/NEJMoa032178 Wert, 2009, Genetic disorders of surfactant dysfunction, Pediatr Dev Pathol, 12, 253, 10.2350/09-01-0586.1 Whitsett, 2010, Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease, Annu Rev Med, 61, 105, 10.1146/annurev.med.60.041807.123500 Gupta, 2017, Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate, Archs Dis Childh, 102, 84, 10.1136/archdischild-2012-303143 Bullard, 2005, ABCA3 mutations associated with pediatric interstitial lung disease, Am J Respir Crit Care Med, 172, 1026, 10.1164/rccm.200503-504OC Nogee, 2001, A mutation in the surfactant protein C gene associated with familial interstitial lung disease, N Engl J Med, 344, 573, 10.1056/NEJM200102223440805 Wambach, 2014, Genotype–phenotype correlations for infants and children with ABCA3 deficiency, Am J Respir Crit Care Med, 189, 1538, 10.1164/rccm.201402-0342OC Trapnell, 2009, Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages, Curr Opin Immunol, 21, 514, 10.1016/j.coi.2009.09.004 Suzuki, 2011, Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations, Eur Respir J, 37, 201, 10.1183/09031936.00090610 Suzuki, 2008, Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA, J Exp Med, 205, 2703, 10.1084/jem.20080990 Tanaka, 2011, Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB, J Med Genet, 48, 205, 10.1136/jmg.2010.082586 Soares, 2013, Childhood interstitial lung diseases: an 18-year retrospective analysis, Pediatrics, 132, 684, 10.1542/peds.2013-1780 Brody, 2010, Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT, Am J Roentgenol, 194, 238, 10.2214/AJR.09.2743 Young, 2011, Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders, Chest, 139, 1060, 10.1378/chest.10-1304 Rauch, 2016, Persistent tachypnea of infancy. Usual and aberrant, Am J Respir Crit Care Med, 193, 438, 10.1164/rccm.201508-1655OC Popler, 2010, Familial neuroendocrine cell hyperplasia of infancy, Pediatr Pulmonol, 45, 749, 10.1002/ppul.21219 Young, 2013, A mutation in TTF1/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy, Chest, 144, 1199, 10.1378/chest.13-0811 Canakis, 2002, Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease, Am J Respir Crit Care Med, 165, 1557, 10.1164/rccm.2105139 Jiskoot-Ermers, 2015, Irreversible respiratory failure in a full-term infant with features of pulmonary interstitial glycogenosis as well as bronchopulmonary dysplasia, Am J Perinatol Rep, 5, e136, 10.1055/s-0035-1551674 King, 2011, Pulmonary maturational arrest and death in a patient with pulmonary interstitial glycogenosis, Pediatr Pulmonol, 46, 1142, 10.1002/ppul.21486 Davis, 2015, Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype, Am J Respir Crit Care Med, 191, 316, 10.1164/rccm.201409-1672OC Leigh, 2016, Clinical features and associated likelihood of primary ciliary dyskinesia in children and adolescents, Ann Am Thorac Soc, 13, 1305, 10.1513/AnnalsATS.201511-748OC Mullowney, 2014, Primary ciliary dyskinesia and neonatal respiratory distress, Pediatrics, 134, 1160, 10.1542/peds.2014-0808 Liu, 2014, Activated STING in a vascular and pulmonary syndrome, N Engl J Med, 371, 507, 10.1056/NEJMoa1312625 Vece, 2016, Copa syndrome: a novel autosomal dominant immune dysregulatory disease, J Clin Immunol, 36, 377, 10.1007/s10875-016-0271-8 Bush, 2015, European protocols for the diagnosis and initial treatment of interstitial lung disease in children, Thorax, 70, 1078, 10.1136/thoraxjnl-2015-207349 Kurland, 2013, An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy, Am J Respir Crit Care Med, 188, 376, 10.1164/rccm.201305-0923ST